Loading clinical trials...
Loading clinical trials...
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer "SPECTAcolor"
The EORTC GastroIntestinal Tract Cancer Group and the EORTC HeadQuarters wish to set up a European screening platform for advanced colo-rectal cancer (CRC) patients. The goal of this screening platform is to provide quick access to new drugs to patients by offering a new structure for clinical trials. Currently some of the most challenging clinical questions arise from the molecular sub-division of CRC that would theoretically allow to inhibit the specific, altered pathways in the patients. A major problem for trials in this "personalized medicine" is that the low frequency of the different mutations requires a high effort for screening and identifying the patients. The EORTC CRC screening platform will hopefully offer a feasible and efficient way to characterize the patients on the molecular basis of their tumors and allow to offer them rapid and preferential participation in clinical studies with new drugs targeted to their specific pathway alterations.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet
Brussels, Belgium
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium
Bank Of Cyprus Oncology Centre
Stróvolos, Cyprus
Gustave Roussy Cancer Campus
Villejuif, France
Universitaetsklinikum Carl Gustav Carus
Dresden, Germany
Universitaets-Krankenhaus Eppendorf
Hamburg, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Start Date
September 1, 2013
Primary Completion Date
April 10, 2019
Completion Date
March 10, 2020
Last Updated
July 7, 2022
668
ACTUAL participants
Tumour markers testing
GENETIC
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
NCT06696768
NCT04704661
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions